
iCura Diagnostics is a CLIA and CAP certified high-complexity laboratory based in Philadelphia specializing in advanced digital pathology and spatial biology services. The company offers a broad portfolio including digital pathology with quantitative analysis for IHC, FISH, CISH, RNAScope, multiplex immunofluorescence (mIF) with custom panels, and comprehensive genomics services such as NGS, digital PCR, and spatial transcriptomics. iCura supports precision therapeutics and drug development with tailored solutions, clinical trial logistics, and expert project management by board-certified pathologists and scientists. Their validated panels and advanced equipment position them as a leader in precision medicine and biomarker research for pharmaceutical companies and clinical studies worldwide.

iCura Diagnostics is a CLIA and CAP certified high-complexity laboratory based in Philadelphia specializing in advanced digital pathology and spatial biology services. The company offers a broad portfolio including digital pathology with quantitative analysis for IHC, FISH, CISH, RNAScope, multiplex immunofluorescence (mIF) with custom panels, and comprehensive genomics services such as NGS, digital PCR, and spatial transcriptomics. iCura supports precision therapeutics and drug development with tailored solutions, clinical trial logistics, and expert project management by board-certified pathologists and scientists. Their validated panels and advanced equipment position them as a leader in precision medicine and biomarker research for pharmaceutical companies and clinical studies worldwide.